Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Beta Drugs Ltd.
Swot
Beta Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Beta Drugs Ltd. has 13 Strengths, 7 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(7)
Opportunity
(0)
Threats
(0)
Others
(2)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Company with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Bullish or Bearish Candlestick Strength - Indices
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
